Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

16 trials with published results (22%)

Research Maturity

52 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

5.6%

4 terminated out of 72 trials

Success Rate

92.9%

+6.3% vs benchmark

Late-Stage Pipeline

26%

19 trials in Phase 3/4

Results Transparency

31%

16 of 52 completed with results

Key Signals

16 with results93% success

Data Visualizations

Phase Distribution

57Total
Not Applicable (28)
P 1 (1)
P 2 (9)
P 3 (9)
P 4 (10)

Trial Status

Completed52
Unknown9
Terminated4
Not Yet Recruiting3
Recruiting2
Withdrawn1

Trial Success Rate

92.9%

Benchmark: 86.5%

Based on 52 completed trials

Clinical Trials (72)

Showing 20 of 20 trials
NCT07665476Phase 3Not Yet RecruitingPrimary

Naproxen Versus Placebo as Adjunct Treatment of Cellulitis

NCT06526884Not ApplicableCompleted

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

NCT07492030Not Yet Recruiting

Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions

NCT07532941Phase 4Not Yet Recruiting

Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'

NCT00323219Phase 3CompletedPrimary

Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency Department

NCT05023200CompletedPrimary

The Personalised Antibiotic Duration for Cellulitis (PAD-C) Study

NCT06715306Not ApplicableRecruiting

Intravenous Versus Oral Treatment of the Main Acute Infections

NCT01706913Not ApplicableCompletedPrimary

Study Assessing Impact of Dermatology Consultation for Patients Admitted With Cellulitis

NCT05852262Phase 4Enrolling By InvitationPrimary

High-dose Cephalexin for Cellulitis (HI-DOCC)

NCT07093749Not ApplicableRecruiting

Perspectives on Antibiotics and Tracking Symptoms in Children

NCT05226260Not ApplicableCompletedPrimary

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care

NCT03785834CompletedPrimary

The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and Pseudocellulitis

NCT04471246Phase 4CompletedPrimary

High-dose vs. Standard-dose Cephalexin for Cellulitis

NCT04091672Not ApplicableCompleted

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

NCT05959928Completed

Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture

NCT04928235CompletedPrimary

Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency Department

NCT05624216Not ApplicableCompleted

Radiofrequency and Targeted Pressure Energy for Cellulite Reduction

NCT02334124Not ApplicableCompletedPrimary

Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital

NCT01876628Phase 4CompletedPrimary

Adjunctive Clindamycin for Cellulitis: C4C Trial.

NCT05473325Unknown

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

Scroll to load more

Research Network

Activity Timeline